PMA supplement
P980040 S149: TECNIS® Symfony™, TECNIS® Symfony™ Toric, TECNIS® Symfony™ OptiBlue®, TECNIS® Symfony™ OptiBlue® with TECNIS Simplicity®
FDA PMA supplement · 30-Day Notice · Johnson & Johnson Surgical Vision, Inc.
Key facts
| Original PMA | P980040 |
|---|---|
| Supplement number | S149 |
| Supplement type | 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | TECNIS® Symfony™, TECNIS® Symfony™ Toric, TECNIS® Symfony™ OptiBlue®, TECNIS® Symfony™ OptiBlue® with TECNIS Simplicity® |
| Generic name | Intraocular lens |
| Applicant | Johnson & Johnson Surgical Vision, Inc. |
| Product code | HQL |
| Received date | Jul 1, 2022 |
| Decision date | Jul 25, 2022 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: